Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.96 USD | +0.22% | +0.67% | +60.36% |
Jun. 05 | Harrow, Inc. Announces 52-Week Data from VEVYE ESSENCE-2 Open-Label Extension Study | CI |
Jun. 03 | Lake Street Raises Price Target on Harrow to $25 From $20, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.36% | 634M | |
+43.64% | 749B | |
+39.42% | 605B | |
-6.58% | 351B | |
+19.72% | 328B | |
+8.78% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.03% | 167B | |
+6.13% | 165B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- B. Riley Raises Harrow Health's PT to $45 From $42 on Heels of Announced Transactions With Santen, Novaliq; Keeps Buy Rating